Clinical Trials List
2022-03-31 - 2024-08-30
Phase II
Not yet recruiting8
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10E11.22
Type 2 diabetes mellitus with diabetic chronic kidney disease
ICD-10E11.29
Type 2 diabetes mellitus with other diabetic kidney complication
ICD-10E11.65
Type 2 diabetes mellitus with hyperglycemia
ICD-9250.42
Diabetes with renal manifestations, Type II [non-insulin dependent type][NIDDM type][adult-onset type] or unspecified type, uncontrolled
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wen-Chin Lee Division of Nephrology
- 李隆志 Division of Nephrology
- 陳德全 Division of Nephrology
- 邱鼎育 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chia-Te Liao Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- Yu-Wei Chen Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wei-Cheng Tseng Division of Nephrology
- Yao-Ping Lin Division of Nephrology
- 蔡明村 Division of Nephrology
- 歐朔銘 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
807 participants
